BME grad student Rachel Edelstein received Honorable Mention in the 2015 NSF Graduate Research Fellowship Program (GRFP) competition for her proposed research on utilizing actively targeted nanoparticles coated with antibodies and small interfering RNA for the treatment of Triple Negative Breast Cancer, a form of breast cancer that is ineligible for many conventional treatments because it lacks the appropriate receptors.